A single scratch, burn, or bite can result in hyperpigmentation
Changes in diabetes therapy were evaluated descriptively due to incomplete structured dose documentation and heterogeneity in regimens
Unreconstituted lyophilized powder remains stable at room temperature but benefits from refrigeration for extended storage
Perioperative Management Strategies Stable, low-risk patients For most stable patients without active gastrointestinal symptoms and not in the dose-escalation phase, continuation of GLP-1 therapy is reasonable under the 2024 multi-society guidance
The integration of technology, community support, and evidence-based medication will shape the future of diabetes care, ensuring better outcomes for patients worldwide
NORMAN SWAN: But nonetheless, you got the prescription